Genesung & Heilung

BPC-157 / TB-500

Preisspanne: 375,00 $ bis 725,00 $

Per vial
$37.50
10 vials per pack
Suggested retail
$112.50
3× markup · per vial
Kostenloser Versand bei Bestellungen über 2.000 $
  • Liefergarantie Kostenloser Nachversand, falls die Lieferung nicht ankommt
  • Reinheit ≥ 99 % Direkt vom Hersteller
  • Unabhängige Echtheitszertifikate COAs für dieses Produkt anzeigen →
  • Garantie auf Gutschriften Senden Sie uns ein beliebiges COA-Ergebnis und erhalten Sie eine Gutschrift

BPC-157 / TB-500 Blend — Paired Tissue Repair Peptides

This blend combines two of the most widely studied repair-focused research peptides in a single vial: BPC-157 (Body Protection Compound-157, a 15-amino-acid fragment originally isolated from human gastric juice) and TB-500 (the synthetic N-terminal fragment of Thymosin Beta-4). Researchers pair them because each peptide acts through a different mechanism: BPC-157 is most closely associated with angiogenic (blood-vessel-forming) pathways and gut signaling, while TB-500 is associated with actin regulation and cell migration. Combining them lets researchers study the two mechanisms on the same timeline without running parallel experiments.


Why Researchers Pair Them

BPC-157 and TB-500 target different parts of the tissue-repair cascade. BPC-157 is most often cited in literature on vascular formation (angiogenesis) and gastrointestinal signaling, and it has an unusually stable oral profile for a peptide. TB-500 is studied for its effect on cellular migration, actin polymerization, and recruitment of repair cells to injured tissue. The pair is sometimes described as a “scaffold plus traffic” combination: one builds the structural substrate, the other moves repair cells into position.

Peptid Primary pathway in literature Most-studied tissue
BPC-157 Angiogenesis (VEGF), nitric-oxide signaling, gut-brain axis GI tract, tendon, ligament
TB-500 Actin binding, cell migration, anti-inflammatory signaling Muscle, cardiovascular, skin

Forschungsanwendungen

The blend is used in studies examining:

  • Soft-tissue repair models – tendon, ligament, and muscle
  • Gastrointestinal protection and mucosal repair models
  • Vascular formation and wound-healing substrates
  • Cross-mechanism study designs comparing single-peptide vs. stacked protocols
  • Recovery modeling after controlled tissue injury

Technische Daten

Format Lyophilized powder, both peptides co-lyophilized
Reinheit ≥99% each peptide
Aliasnamen BPC-157/TB-500, BPC/TB blend, BPC-TB-500
Verfügbare Größen 5mg BPC-157 + 5mg TB-500 · 10mg BPC-157 + 10mg TB-500
Lagerung 2–8 °C ungeöffnet; mindestens 12 Monate haltbar
Verwendung Nur für Forschungszwecke – nicht zur Anwendung am Menschen

Rekonstitution

The blend arrives as a co-lyophilized powder and is reconstituted like any single-peptide vial:

Gesamtmenge in mg im Fläschchen ÷ hinzugefügte Wassermenge in ml = mg pro ml

Example: a 5/5mg vial (10mg total peptide) + 2mL of bacteriostatic water = 5mg per mL of total blend, which delivers 2.5mg BPC-157 and 2.5mg TB-500 per mL.

Nach der Zubereitung bei 2–8 °C lagern und innerhalb von 28–30 Tagen verbrauchen.


Anmerkungen zum Protokoll

The following values are reference points extracted from published BPC-157 and TB-500 research – not instructions. Published protocols pair the two peptides at roughly equivalent milligram doses and run them for short, defined study windows.

  • Starting doses reported in the literature: 250-500mcg of each peptide per administration
  • Administration frequency in published studies: Daily for BPC-157; 2-4x weekly for TB-500 in most reports (TB-500 has a longer half-life)
  • Study durations reported: 4-8 weeks for acute tissue-repair endpoints

Common Questions About the Blend

What are BPC-157 and TB-500 used for in research?

Both peptides are studied in tissue-repair models. BPC-157 is most often cited in gastrointestinal and vascular-repair literature; TB-500 is most often cited in muscle-injury and cardiovascular-repair literature. Researchers pair them to study the two mechanisms simultaneously.

Why combine BPC-157 with TB-500 instead of using either alone?

The peptides act through different pathways – angiogenesis (BPC-157) and actin-mediated cell migration (TB-500) – which lets researchers characterize the combined effect within a single study timeline. Published protocols typically report a roughly 1:1 ratio.

How does the blend differ from GLOW?

GLOW is a three-peptide blend (BPC-157 + TB-4 + GHK-Cu) that adds a copper peptide to the BPC-157/TB-500 base. This 2-peptide blend is simpler and lets researchers study the BPC/TB-500 pair without the added GHK-Cu variable.

Is the BPC-157 / TB-500 blend FDA approved?

No. Neither BPC-157 nor TB-500 is FDA approved for any human use. TB-500 (Thymosin Beta-4) is listed on the WADA Prohibited List for competitive athletes. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is the blend stored?

Ungeöffnete Fläschchen werden bei 2–8 °C gelagert und sind mindestens 12 Monate haltbar. Nach der Rekonstitution mit bakteriostatischem Wasser wird die Lösung bei 2–8 °C aufbewahrt und innerhalb von 28–30 Tagen verbraucht.


Reinheitsgarantie

Jede Charge weist eine Reinheit von ≥99 % auf. Senden Sie uns ein Analysezertifikat einer unabhängigen Prüfstelle, und wir stellen Ihnen unabhängig vom Ergebnis eine Gutschrift aus.